| Literature DB >> 17115930 |
Josephine M Atienza1, Naichen Yu, Shelli L Kirstein, Biao Xi, Xiaobo Wang, Xiao Xu, Yama A Abassi.
Abstract
Cell-based assays have become an integral part of the preclinical drug development process. Recently, noninvasive label-free cell-based assay technologies have taken center stage, offering important and distinct advantages over and in addition to traditional label-based endpoint assays. Dynamic monitoring of live cells, the preclusion of label, and kinetics are some of the fundamental features of cell-based label-free technologies. In this article we will discuss the real-time cell electronic sensing (RT-CES, ACEA Biosciences Inc., San Diego, CA) system and some of its key applications for cell-based assays such as cell proliferation and cytotoxicity, functional assays for receptor-ligand analysis, cell adhesion and spreading assays, dynamic monitoring of endothelial barrier function, and dynamic monitoring of cell migration and invasion. Also, where appropriate we will briefly discuss other label-free technologies in an application-specific manner.Entities:
Mesh:
Year: 2006 PMID: 17115930 DOI: 10.1089/adt.2006.4.597
Source DB: PubMed Journal: Assay Drug Dev Technol ISSN: 1540-658X Impact factor: 1.738